Italija -
angleščina -
Ministero della Salute
spongostan spugna di gelatina emostatica riassorbibile
Malta -
angleščina -
Medicines Authority
bendamustine pdr/conc/soln for infus 2.5mg/ml (25mg vial)
fresenius kabi oncology plc - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
Malta -
angleščina -
Medicines Authority
bendamustine pdr/conc/soln for infus 2.5mg/ml (100mg vial
fresenius kabi oncology plc - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
Malta -
angleščina -
Medicines Authority
bendamustine hydrochloride accord pdr/conc/soln for infus 2.5mg/ml (25mg)
accord healthcare limited - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
Malta -
angleščina -
Medicines Authority
bendamustine hyrochloride accord pdr/conc/soln for infus 2.5mg/ml (100mg)
accord healthcare limited - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
Irska -
angleščina -
HPRA (Health Products Regulatory Authority)
bendamustine 25 mg/ml concentrate for solution for infusion
accord healthcare ireland ltd. - bendamustine hydrochloride - concentrate for solution for infusion - bendamustine
Malta -
angleščina -
Medicines Authority
bendroflumethiazide 2.5mg tablets
crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - bendroflumethiazide - tablet - bendroflumethiazide 2.5 mg - diuretics
Malta -
angleščina -
Medicines Authority
bendroflumethiazide 5mg tablets
crescent pharma international limited 260, triq san albert, gzira gzr 1150, malta - bendroflumethiazide - tablet - bendroflumethiazide 5 mg - diuretics
Izrael -
angleščina -
Ministry of Health
bendamustine medac 100 mg
tzamal bio-pharma ltd - bendamustine hydrochloride - powder for concentrate for solution for infusion - bendamustine hydrochloride 100 mg - bendamustine - first-line treatment of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotherapy is not appropriate.indolent non-hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.